A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer

European Journal of Cancer

Volumn 44, Issue 16, 2008, Pages 2411-2417

  Na, Im Il ^a   Lee, Tae Hyun ^a   Choe, Du Hwan ^a   Cheon, Gi Jeong ^a   Kim, Cheol Hyeon ^a   Koh, Jae Soo ^a   Baek, HeeJong ^a   Ryoo, Baek Yeol ^a   Yang, Sung Hyun ^a   Lee, Jae Cheol ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

Brain metastasis; Magnetic resonance imaging; Non small cell lung cancer

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; MEDRONATE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BRAIN; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC MODEL; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MODEL; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THORAX;

ADULT; AGED; BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 54249101310     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.07.003     Document Type: Article

References (42)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2 9 (2001) 533-543
2. Lee C.-T. Epidemiology of lung cancer in Korea. Cancer Res Treat 34 1 (2002) 3-7
3. Quint L.E., Tummala S., Brisson L.J., et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 62 1 (1996) 246-250
4. Quinn D.L., Ostrow L.B., Porter D.K., Shelton Jr. D.K., and Jackson Jr. D.E. Staging of non-small cell bronchogenic carcinoma. Relationship of the clinical evaluation to organ scans. Chest 89 2 (1986) 270-275
5. Pope R.J., and Hansell D.M. Extra-thoracic staging of lung cancer. Eur J Radiol 45 1 (2003) 31-38
6. Hillers T.K., Sauve M.D., and Guyatt G.H. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer. Thorax 49 1 (1994) 14-19
7. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. New Engl J Med 348 25 (2003) 2500-2507
8. Marom E.M., McAdams H.P., Erasmus J.J., et al. Staging non-small cell lung cancer with whole-body PET. Radiology 212 3 (1999) 803-809
9. Toloza E.M., Harpole L., and McCrory D.C. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 1 Suppl (2003) 137S-146S
10. Yokoi K., Kamiya N., Matsuguma H., et al. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest 115 3 (1999) 714-719
11. Colice G.L., Birkmeyer J.D., Black W.C., Littenberg B., and Silvestri G. Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest 108 5 (1995) 1264-1271
12. The American Thoracic Society and The European Respiratory Society. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 1997;156(1):320-332.
13. Pfister D.G., Johnson D.H., Azzoli C.G., et al. American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 22 2 (2004) 330-353
14. Ferrigno D., and Buccheri G. Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cancer. Chest 106 4 (1994) 1025-1029
15. Bilgin S., Yilmaz A., Ozdemir F., Akkaya E., Karakurt Z., and Poluman A. Extrathoracic staging of non-small cell bronchogenic carcinoma: relationship of the clinical evaluation to organ scans. Respirology 7 1 (2002) 57-61
16. Metintas M., Ak G., Akcayir I.A., et al. Detecting extrathoracic metastases in patients with non-small cell lung cancer: is routine scanning necessary?. Lung Cancer 58 1 (2007) 59-67
17. Bajard A., Westeel V., Dubiez A., et al. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer 45 3 (2004) 317-323
18. Shi A.A., Digumarthy S.R., Temel J.S., Halpern E.F., Kuester L.B., and Aquino S.L. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?. J Thorac Oncol 1 3 (2006) 205-210
19. Postmus P.E., and Smit E.F. Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 10 7 (1999) 753-759
20. Kvale P.A., Selecky P.A., and Prakash U.B. Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed.). Chest 132 3 Suppl. (2007) 368S-403S
21. Cortes J., Rodriguez J., Aramendia J.M., et al. Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer. Oncology 64 1 (2003) 28-35
22. Schellinger P.D., Meinck H.M., and Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 44 3 (1999) 275-281
23. Davis P.C., Hudgins P.A., Peterman S.B., and Hoffman Jr. J.C. Diagnosis of cerebral metastases: double-dose delayed CT vs. contrast-enhanced MR imaging. AJNR Am J Neuroradiol 12 2 (1991) 293-300
24. Erturan S., Yaman M., Aydin G., Uzel I., Musellim B., and Kaynak K. The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer. Chest 127 2 (2005) 449-454
25. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 6 (1997) 1718-1723
26. Kim H.K., Choi Y.S., Kim K., Kim J., and Shim Y.M. Preoperative evaluation of adrenal lesions based on imaging studies and laparoscopic adrenalectomy in patients with otherwise operable lung cancer. Lung Cancer 58 3 (2007) 342-347
27. Kass R., and Raftery A. Bayes factors. J Am Stat Assoc 90 430 (1990) 773-795
28. Simel D.L., Samsa G.P., and Matchar D.B. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 44 8 (1991) 763-770
29. de Cos Escuin J.S., Menna D.M., Gonzalez M.A., Quirantes J.Z., Vicente C.D., and Calvo M.C. Silent brain metastasis in the initial staging of lung cancer: evaluation by computed tomography and magnetic resonance imaging. Arch Bronconeumol 43 7 (2007) 386-391
30. Hochstenbag M.M., Twijnstra A., Hofman P., Wouters E.F., and ten Velde G.P. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment?. Lung Cancer 42 2 (2003) 189-193
31. Mamon H.J., Yeap B.Y., Janne P.A., et al. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol 23 7 (2005) 1530-1537
32. Komaki R., Cox J.D., and Stark R. Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung: correlation with survival. Int J Radiat Oncol Biol Phys 9 10 (1983) 1467-1470
33. Chen A.M., Jahan T.M., Jablons D.M., Garcia J., and Larson D.A. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain. Cancer 109 8 (2007) 1668-1675
34. Ceresoli G.L., Reni M., Chiesa G., et al. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer 95 3 (2002) 605-612
35. Tang S.G., Lin F.J., and Leung W.M. Impact of prophylactic cranial irradiation in adenocarcinoma of the lung. J Formos Med Assoc 92 5 (1993) 413-419
36. Jacobs R.H., Awan A., Bitran J.D., et al. Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role. Cancer 59 12 (1987) 2016-2019
37. Mujoomdar A., Austin J.H., Malhotra R., et al. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology 242 3 (2007) 882-888
38. Earnest Ft., Ryu J.H., Miller G.M., et al. Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection - pilot study. Radiology 211 1 (1999) 137-145
39. Grimes D.A., and Schulz K.F. Refining clinical diagnosis with likelihood ratios. Lancet 365 9469 (2005) 1500-1505
40. Bleeker S.E., Moll H.A., Steyerberg E.W., et al. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol 56 9 (2003) 826-832
41. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. New Engl J Med 322 8 (1990) 494-500
42. Seute T., Leffers P., Wilmink J.T., ten Velde G.P., and Twijnstra A. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. J Clin Oncol 24 13 (2006) 2079-2083